http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2428164-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2629ff59e0d2f7016c3e8e9573d4a9c
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61H39-00
filingDate 2009-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b29205622adecefa5be399fc2978fe9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b4e9c46cb42a5181695eb97ca2492eb
publicationDate 2011-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2428164-C2
titleOfInvention Method of treating tobacco addiction in men
abstract FIELD: medicine. n SUBSTANCE: invention relates to medicine, namely to psychiatry. Method includes determination of form of tobacco addiction and further impact taking into account its form. In case of dissociated form of tobacco addiction impact is performed on adrenergic, dopaminergic and glucocorticoid biologically active systems homolaterally from the left side, and on estrogenic, histaminergic and alimentary systems - bilaterally from both sides. In case of psychosomatic form of tobacco addiction impact is performed on androgenic, adrenergic and dopaminergic biologically active systems homolaterally from the left side, and on histaminergic and alimentary systems - bilaterally from both sides. Impact is performed by method of bioresonance therapy with application of corresponding for each system homeopathic preparation: estradiol-composite, androstendiol-composite, adrenalin-composite, dopamine-composite, glucocorticoid-composite, histamine-composite in hundredth homeopathic potencies and nicotine-composite in two hundredth homeopathic potencies. Impact is performed on all or separate arm or leg meridians of male patient. Impact duration on each biologically active system constitutes 3 minutes. Course of treatment includes 6-15 sessions. n EFFECT: method increases remission duration. n 4 cl, 2 ex, 2 tbl
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2801915-C1
priorityDate 2009-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425165935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574898
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554556
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520607
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502956
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10634
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID774

Total number of triples: 27.